Ryutaro Ikegami

770 total citations
32 papers, 398 citations indexed

About

Ryutaro Ikegami is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Ryutaro Ikegami has authored 32 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 13 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in Ryutaro Ikegami's work include Coronary Interventions and Diagnostics (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers) and Adipose Tissue and Metabolism (5 papers). Ryutaro Ikegami is often cited by papers focused on Coronary Interventions and Diagnostics (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers) and Adipose Tissue and Metabolism (5 papers). Ryutaro Ikegami collaborates with scholars based in Japan, United States and Denmark. Ryutaro Ikegami's co-authors include Tohru Minamino, Ippei Shimizu, Yohko Yoshida, Masayoshi Suda, Goro Katsuumi, Yuka Hayashi, Yoshitaka Hayashi, Tomoyoshi Soga, Kazuyuki Ozaki and Shujiro Okuda and has published in prestigious journals such as Circulation, PLoS ONE and Scientific Reports.

In The Last Decade

Ryutaro Ikegami

29 papers receiving 395 citations

Peers

Ryutaro Ikegami

CCM

PHYSI

SURGE

EDM

Teng Wang China

Hideyuki Kabasawa Japan

Qingwei Chen China

Dominik Schuler Germany

Jacek Rysz Poland

Martina Mihalj Croatia

Xianhua Ye China

Anja Hofmann Germany

Jui‐Fen Lin Taiwan

Teng Wang China

Ryutaro Ikegami

199 ×1.3

179 ×1.4

CCM

55 ×0.5

PHYSI

83 ×1.3

SURGE

41 ×0.8

EDM

Citations per year, relative to Ryutaro Ikegami Ryutaro Ikegami (= 1×) peers Teng Wang

Countries citing papers authored by Ryutaro Ikegami

Since Specialization

Citations

This map shows the geographic impact of Ryutaro Ikegami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryutaro Ikegami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryutaro Ikegami more than expected).

Fields of papers citing papers by Ryutaro Ikegami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryutaro Ikegami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryutaro Ikegami. The network helps show where Ryutaro Ikegami may publish in the future.

Co-authorship network of co-authors of Ryutaro Ikegami

This figure shows the co-authorship network connecting the top 25 collaborators of Ryutaro Ikegami. A scholar is included among the top collaborators of Ryutaro Ikegami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryutaro Ikegami. Ryutaro Ikegami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ozaki, Kazuyuki, Ryutaro Ikegami, Naoki Kubota, et al.. (2024). Pd/Pa fluctuation with continuous ATP administration indicates inaccurate FFR measurement caused by insufficient hyperemia. Heart and Vessels. 40(1). 8–15. 1 indexed citations

Ozaki, Kazuyuki, et al.. (2024). Coronary Aneurysm after Excimer Laser Catheter Ablation and Plain Balloon Angioplasty for Chronic Total Occlusion in a Patient with Kawasaki Disease. Internal Medicine. 63(20). 2801–2806.

Ikegami, Ryutaro, Zhonglie Piao, Juan F. Iglesias, et al.. (2024). Ultrathin-strut versus thin-strut stent healing and outcomes in preclinical and clinical subjects. EuroIntervention. 20(10). e669–e680. 1 indexed citations

Kubota, Naoki, et al.. (2023). Angioscopic Findings of Calcification in Saphenous Vein Graft. Circulation Journal. 87(11). 1705–1705.

Ozaki, Kazuyuki, Naoki Kubota, Takeshi Okubo, et al.. (2023). Efficacy of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Treatment for Repeated In-stent Restenosis in a Coronary Artery. Internal Medicine. 62(22). 3361–3365. 1 indexed citations

Hayashi, Yuka, Ippei Shimizu, Yohko Yoshida, et al.. (2022). Coagulation factors promote brown adipose tissue dysfunction and abnormal systemic metabolism in obesity. iScience. 25(7). 104547–104547. 10 indexed citations

Kubota, Naoki, Kazuyuki Ozaki, Takeshi Okubo, et al.. (2022). Correlation Between the Japanese Version of the High Bleeding Risk (J-HBR) Criteria and the PRECISE-DAPT Score, and Optimal J-HBR Cut-Off Score to Predict Major Bleeding. Circulation Reports. 4(8). 363–370. 4 indexed citations

Albaghdadi, Mazen, Ryutaro Ikegami, Mohamad Kassab, et al.. (2021). Near-Infrared Autofluorescence in Atherosclerosis Associates With Ceroid and Is Generated by Oxidized Lipid-Induced Oxidative Stress. Arteriosclerosis Thrombosis and Vascular Biology. 41(7). e385–e398. 18 indexed citations

Ozaki, Kazuyuki, Ryutaro Ikegami, Naoki Kubota, et al.. (2021). Conservative treatment with an intra-aortic balloon pump to treat acute myocardial infarction due to spontaneous coronary artery dissection. Journal of Cardiology Cases. 23(6). 274–280. 2 indexed citations

10.

Shimizu, Ippei, Yohko Yoshida, Ryutaro Ikegami, et al.. (2021). Cardiac mitofusin-1 is reduced in non-responding patients with idiopathic dilated cardiomyopathy. Scientific Reports. 11(1). 6722–6722. 22 indexed citations

11.

Shimizu, Ippei, Goro Katsuumi, Yohko Yoshida, et al.. (2021). Empagliflozin maintains capillarization and improves cardiac function in a murine model of left ventricular pressure overload. Scientific Reports. 11(1). 18384–18384. 29 indexed citations

12.

Shimizu, Ippei, Yohko Yoshida, Yuka Hayashi, et al.. (2019). Role of smooth muscle cell p53 in pulmonary arterial hypertension. PLoS ONE. 14(2). e0212889–e0212889. 32 indexed citations

13.

Yokoyama, Masataka, Ippei Shimizu, Ayako Nagasawa, et al.. (2019). p53 plays a crucial role in endothelial dysfunction associated with hyperglycemia and ischemia. Journal of Molecular and Cellular Cardiology. 129. 105–117. 44 indexed citations

14.

Yoshida, Yohko, Ippei Shimizu, Yoshitaka Hayashi, et al.. (2019). Peptide vaccine for semaphorin3E ameliorates systemic glucose intolerance in mice with dietary obesity. Scientific Reports. 9(1). 3858–3858. 8 indexed citations

15.

Shimizu, Ippei, Yohko Yoshida, Yuka Hayashi, et al.. (2018). Boysenberry polyphenol inhibits endothelial dysfunction and improves vascular health. PLoS ONE. 13(8). e0202051–e0202051. 44 indexed citations

16.

Ikegami, Ryutaro, Ippei Shimizu, Takeshi Sato, et al.. (2018). Gamma-Aminobutyric Acid Signaling in Brown Adipose Tissue Promotes Systemic Metabolic Derangement in Obesity. Cell Reports. 24(11). 2827–2837.e5. 41 indexed citations

17.

Suda, Masayoshi, Ippei Shimizu, Yohko Yoshida, et al.. (2017). Inhibition of dipeptidyl peptidase-4 ameliorates cardiac ischemia and systolic dysfunction by up-regulating the FGF-2/EGR-1 pathway. PLoS ONE. 12(8). e0182422–e0182422. 18 indexed citations

18.

Ikegami, Ryutaro, Ippei Shimizu, Takeshi Sato, et al.. (2015). Abstract 12631: Peripheral Gamma-aminobutyric Acid(gaba) Signaling in Brown Adipose Tissue Induces Metabolic Dysfunction in Obesity. Circulation. 132(suppl_3).

19.

Tsuchida, Keiichi, Ryutaro Ikegami, Michio Sato, et al.. (2014). Primary percutaneous coronary intervention and bleeding risk in the era of drug-eluting stent: a long-term cohort study. Cardiovascular Intervention and Therapeutics. 30(3). 216–226. 4 indexed citations

20.

Yamada, Manabu, K. Nakamura, Yoshihiro Kaku, et al.. (2004). Enterovirus encephalomyelitis in pigs in Japan caused by porcine teschovirus. Veterinary Record. 155(10). 304–306. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact